Lexeo Therapeutics, Inc. Common Stock
← Back to LXEO Overview

Lexeo Therapeutics, Inc. Common Stock (LXEO)

Earnings & Profitability History

Latest EPS

$0.06

Net Income

-20919000

Financial Fundamentals

LXEOQuarterly Data • 5Y View

Historical Data Table

Quarterly Net Income & EPS

DateNet Income ($B)NI YoY %TTM NIEPSEPS YoY %TTM EPS
2025-12-31-0.02+19.3%-0.100.06+107.7%-1.86
2025-09-30-0.02+31.2%-0.10-0.33+62.9%-2.70
2025-06-30-0.03-22.9%-0.11-0.60+6.3%-3.26
2025-03-31-0.03-50.6%-0.11-0.99-28.6%-3.30
2024-12-31-0.03-82.7%-0.10-0.78-50.0%-3.08
2024-09-30-0.03-46.7%-0.09-0.89-11.2%-2.82
2024-06-30-0.02-58.0%-0.08-0.64-20.8%-2.73
2024-03-31-0.02-16.2%-0.07-0.77-4.1%-2.62
2023-12-31-0.01+2.7%-0.07-0.52+10.3%-2.59
2023-09-30-0.02-17.9%-0.07-0.80-17.6%-2.65
2023-06-30-0.01+11.2%-0.06-0.53+11.7%-2.53
2023-03-31-0.02-49.2%-0.07-0.74-57.4%-2.60
2022-12-31-0.01-0.06-0.58-2.33
2022-09-30-0.02-0.68
2022-06-30-0.02-0.60
2022-03-31-0.01-0.47

Annual Performance

YearNet Income ($B)Growth %EPSEPS Growth %
2025-0.10-1.7%-1.86+39.8%
2024-0.10-48.1%-3.09-24.1%
2023-0.07-12.0%-2.49-5.5%
2022-0.06-17.1%-2.36-17.4%
2021-0.05-882.4%-2.01-905.0%
2020-0.01-0.20